Gilead Sciences reported $3.08 a share in earnings last night. It beat consensus.It is a $0.05 a share beat.The bad news is troubling. Gilead's Average price per patient is falling. Patient starts is falling.The stock is set for a drop. Buy at $75 - $79. Agree or disagree?My track record on GILD per tipranks: